Marí-Alexandre Josep, Sánchez-Izquierdo Dolors, Gilabert-Estellés Juan, Barceló-Molina Moisés, Braza-Boïls Aitana, Sandoval Juan
Unit of Hemostasia, Thrombosis, Atherosclerosis and Vascular Biology, Health Research Institute La Fe, Valencia 46026, Spain.
Arrays Unit, Health Research Institute La Fe, Valencia 46026, Spain.
Int J Mol Sci. 2016 Jan 13;17(1):93. doi: 10.3390/ijms17010093.
MicroRNAs (miRNAs) are small non-coding RNAs (18-22 nt) that function as modulators of gene expression. Since their discovery in 1993 in C. elegans, our knowledge about their biogenesis, function, and mechanism of action has increased enormously, especially in recent years, with the development of deep-sequencing technologies. New biogenesis pathways and sources of miRNAs are changing our concept about these molecules. The study of the miRNA contribution to pathological states is a field of great interest in research. Different groups have reported the implication of miRNAs in pathologies such as cancer, diabetes, cardiovascular, and gynecological diseases. It is also well-known that miRNAs are present in biofluids (plasma, serum, urine, semen, and menstrual blood) and have been proposed as ideal candidates as disease biomarkers. The goal of this review is to highlight the current knowledge in the field of miRNAs with a special emphasis to their role in endometriosis and the newest investigations addressing the use of miRNAs as biomarkers for this gynecological disease.
微小RNA(miRNA)是一类小的非编码RNA(18 - 22个核苷酸),作为基因表达的调节因子发挥作用。自1993年在秀丽隐杆线虫中发现以来,我们对其生物合成、功能及作用机制的了解大幅增加,尤其是近年来随着深度测序技术的发展。新的miRNA生物合成途径和来源正在改变我们对这些分子的认识。研究miRNA在病理状态中的作用是一个备受关注的研究领域。不同的研究小组报道了miRNA在癌症、糖尿病、心血管疾病和妇科疾病等病理状态中的作用。众所周知,miRNA存在于生物流体(血浆、血清、尿液、精液和月经血)中,并被认为是理想的疾病生物标志物候选物。本综述的目的是突出miRNA领域的当前知识,特别强调其在子宫内膜异位症中的作用以及关于将miRNA用作这种妇科疾病生物标志物的最新研究。